Skip to content

SEED-LVPEI Myopia Study

Efficacy of SEED's Novel Anti-myopia Contact Lens (Daily Disposable) in Controlling Myopia Progression

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04618510
Acronym
SLIMS
Enrollment
108
Registered
2020-11-06
Start date
2020-12-11
Completion date
2022-08-30
Last updated
2021-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

Myopia, Contact Lens, Peripheral Defocus, Multi-focal, India, Extended Depth of Focus

Brief summary

This randomized clinical trial study aims to investigate the efficacy of novel SEED's EDOF based mid-lens design in controlling the myopia progression in Indian children with these specific objectives: 1. To investigate the efficacy of SEED's 1-day pure extended depth of focus lenses controlling myopia progression in Indian children through a one-year randomized clinical study. 2. To investigate the role of SEED's 1-day pure extended depth of focus lenses in altering peripheral refraction of the eye to control myopia progression. 3. To determine if there is any specific cohort that shows better efficacy in myopia control with 1-day pure extended depth of focus lenses based on central and peripheral optics (degree of myopia and optical parameters). 4. To investigate the qualitative assessment of comfort and visual experience with the SEED's EDOF contact lenses through the questionnaire method.

Detailed description

This prospective randomized controlled clinical trial will be conducted in Myopia Research Lab, L V Prasad Eye Institute, Hyderabad and the study protocol will adhere to the tenets of the Declaration of Helsinki. Participants will be recruited through advertisements in local print media (newspaper), approaching schools, through clinical referrals. Children will be assigned to either the control group or intervention group randomly based on computer-generated random numbers operated by the investigator. All participants will undergo a cycloplegic refractive error assessment after the instillation of tropicamide 1% eye drops (or cyclopentolate 1% eye drops in case of varying refractive error between objective and subjective values). Axial length and cycloplegic refractive measurements will be taken with using Lenstar LS900 biometer and Shin- Nippon autorefractor respectively for scheduled follow up and will be compared with the baseline parameters.

Interventions

DEVICESEED 1-dayPure EDOF soft contact lens

Centre-distance contact lens with peripheral add power working on extended depth of focus principle to control myopia

These are the type of glasses that correct vision for a single distance

Sponsors

SEED Co. Ltd.
CollaboratorUNKNOWN
L.V. Prasad Eye Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Single Masked Randomized Study

Eligibility

Sex/Gender
ALL
Age
7 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

* Myopia (SE) between -0.50D to -10.00D * Astigmatism less than 0.75D * Anisometropia less than 1.00D * Age of the participant from 7 to 15 years * Neophyte or existing soft contact lens wearer * Best-corrected visual acuity (BCVA); ≤ 20/20 * Participants who are willing to wear the contact lens constantly

Exclusion criteria

* Participants who had any ocular or systemic conditions that could influence the refractive error * Poor compliance of contact lenses from existing wearer * Prior use of orthokeratology lenses/bifocal lenses/anti-myopia strategies * Participants who had any medications that could influence the refractive error

Design outcomes

Primary

MeasureTime frameDescription
Central refractive error changesData will be collected at baseline, 3 months, 6 months and 12 months.1. Changes (1 year) in spherical equivalent refractive error (dioptre) in the intervention and control group from the baseline. 2. Changes (1 year) in spherical equivalent refractive error (dioptre) among different degrees of myopia in the intervention and control group from the baseline.
Axial length changesData will be collected at baseline, 3 months, 6 months and 12 months.1. Changes (1 year) in axial length (millimetre) in the intervention and control group from the baseline. 2. Changes (1 year) in axial length (millimetre) among different degrees of myopia in the intervention and control group from the baseline.
Peripheral refractive error changesData will be collected at baseline, 3 months, 6 months and 12 months.1. Changes (1 year) in peripheral spherical equivalent refractive error (dioptre) of the individuals in the intervention and control group from the baseline. 2. Changes (1 year) in peripheral spherical equivalent refractive error (dioptre) among different degrees of myopia in the intervention and control group from the baseline.

Secondary

MeasureTime frameDescription
Qualitative assessmentData will be collected at 3 months, 6 months and 12 months.Qualitative assessment of discomfort and visual experience of centre-distance multifocal contact lens will be measured on a scale of 0-4 (0=Never, 1=Rarely, 2=Sometimes, 3=Often, 4=Always).

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026